| Roden, Michael |
| Active, not recruiting | 4 | 192 | Europe | Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector, Jardiance(R), Ozempic(R), Empagliflozin 10mg oral tablet and placebo pen injector matching semaglutide, Jardiance(R), Placebo matching empagliflozin and placebo pen injector matching semaglutide, Control / Placebo | German Diabetes Center, Boehringer Ingelheim, German Center for Diabetes Research, Federal Ministry of Health, Germany, Ministry of Innovation, Science and Research in North Rhine-Westphalia, Novo Nordisk A/S | Type 2 Diabetes, Non-alcoholic Steatohepatitis (NASH), Non-alcoholic Fatty Liver Disease (NAFLD) | 01/25 | 12/25 | | |
NCT05160272: Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients With Type 2 Diabetes |
|
|
| Recruiting | 2 | 38 | Europe | AP-325, Placebo matching AP-325 | The Deutsche Diabetes Forschungsgesellschaft e.V., Algiax Pharmaceuticals GmbH | Type2 Diabetes | 01/25 | 06/25 | | |
| Recruiting | N/A | 400 | Europe | No intervention | German Diabetes Center, Lukas Hospital, Neuss, Germany, Heinrich-Heine University, Duesseldorf, Florence Nightingale Hospital, Düsseldorf, Germany | Diabetes Mellitus | 12/30 | 12/35 | | |
| Recruiting | N/A | 200 | Europe | Intermittent fasting, Control diet | University Hospital Tuebingen, German Institute of Human Nutrition, Charite University, Berlin, Germany, University Hospital Carl Gustav Carus, University of Leipzig, Ludwig-Maximilians - University of Munich, University Hospital Heidelberg, University of Luebeck, German Diabetes-Center, Leibniz-Institut in Düsseldorf, German Center for Diabetes Research | PreDiabetes, Diabetes type2, Intermittent Fasting, Insulin Secretion | 12/24 | 03/25 | | |
| Recruiting | N/A | 450 | Europe | surgery, bariatric surgery | German Diabetes Center, Dep.of General-, Visceral- and Pediatric Surgery, HHU, Duesseldorf, Dep.for Metabolic Diseases, HHU, Duesseldorf | Obesity, Diabetes Mellitus, Type 2 | 12/28 | 12/28 | | |
RESIST, NCT04222231: ! Blood-flow Restriction Resistance Training for Improving Insulin Sensitivity in Type 2 Diabetes |
|
|
| Recruiting | N/A | 24 | Europe | Blood-flow restriction resistance training, Classical resistance training | German Diabetes Center | Type 2 Diabetes | 12/23 | 03/24 | | |
| Recruiting | N/A | 32 | Europe | High-fat overnutrition, Normocaloric macronutrient-balanced nutrition | German Diabetes Center, Yale University | Lipid-induced Insulin Resistance | 12/25 | 12/30 | | |
NCT04088851: "The Role of the Liver for Interorgan Metabolic Crosstalk in Type 2 Diabetes" |
|
|
| Enrolling by invitation | N/A | 12 | Europe | On Metformin, Off Metformin | German Diabetes Center, Yale University | Type2 Diabetes | 12/24 | 12/24 | | |
NCT01055093: Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients |
|
|
| Recruiting | N/A | 2000 | Europe | | German Diabetes Center | Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/25 | 09/35 | | |
| Recruiting | N/A | 200 | Europe | percutaneous transluminal angioplasty | Heinrich-Heine University, Duesseldorf, German Diabetes Center | Diabetic Foot, Diabetes Mellitus, Peripheral Arterial Disease, Diabetic Neuropathies, Diabetic Retinopathy, Anemia, Ulcer Foot, Ulcer Ischemic, Diabetic Polyneuropathy | 02/28 | 11/28 | | |
DISTEMI, NCT05046483: Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI |
|
|
| Recruiting | N/A | 300 | Europe | | German Diabetes Center | ST-segment Elevation Myocardial Infarction (STEMI), Diabetes Mellitus, Insulin Resistance, Non-Alcoholic Fatty Liver Disease | 12/28 | 12/29 | | |
| Szendrödi, Julia |
NCT06054035: SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes |
|
|
| Recruiting | 4 | 182 | Europe | Dapagliflozin (Forxiga®), Placebo matching Dapaglifolzin, Lifestyle Intervention | University Hospital Tuebingen, German Federal Ministry of Education and Research, German Center for Diabetes Research, AstraZeneca | Type2diabetes, PreDiabetes, Renal Failure | 03/26 | 12/26 | | |
| Recruiting | N/A | 200 | Europe | Intermittent fasting, Control diet | University Hospital Tuebingen, German Institute of Human Nutrition, Charite University, Berlin, Germany, University Hospital Carl Gustav Carus, University of Leipzig, Ludwig-Maximilians - University of Munich, University Hospital Heidelberg, University of Luebeck, German Diabetes-Center, Leibniz-Institut in Düsseldorf, German Center for Diabetes Research | PreDiabetes, Diabetes type2, Intermittent Fasting, Insulin Secretion | 12/24 | 03/25 | | |
DISTEMI, NCT05046483: Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI |
|
|
| Recruiting | N/A | 300 | Europe | | German Diabetes Center | ST-segment Elevation Myocardial Infarction (STEMI), Diabetes Mellitus, Insulin Resistance, Non-Alcoholic Fatty Liver Disease | 12/28 | 12/29 | | |
